Restriction Spectrum Imaging (RSI) improves cancer detection

November 18, 2023
< 1 mins

Category: Published research
Product: OnQ Prostate
Disease: Prostate cancer

Compares the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. 2016.

Read Here >>

Topic: Published research

More Resources

10/14/2026

Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions

Cortechs.ai joins CARPL.ai’s enterprise AI ecosystem to expand access to quantitative imaging solutions worldwide.

Product updates

10/10/2026

World Mental Health Day: Why Brain Health and Mental Health Belong Together

Behind every brain scan is a person. Here’s why their voice matters.

Blogs

09/30/2026

Today’s Examination Becomes Tomorrow’s Baseline: The Benefits of Performing Quantitative Analysis on Every Brain MRI

A single brain MRI shows where a patient is today. A quantitative baseline can help show how the brain changes over time.

Blogs

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

Blogs

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

Blogs

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

Our solutions

Our solutions

About

Support

Resources